Gura T A, Wright K L, Veis A, Webb C L
Division of Pediatric Cardiology, Children's Memorial Hospital, Northwestern University Medical Center, Chicago, Illinois 60614, USA.
J Biomed Mater Res. 1997 Jun 15;35(4):483-95. doi: 10.1002/(sici)1097-4636(19970615)35:4<483::aid-jbm8>3.0.co;2-d.
Calcification of glutaraldehyde-preserved bioprosthetic heart valves (BHVs) results in their clinical failure. The mechanism of this pathologic calcification is not well defined. Since serum proteins are known to be taken up in mineralized tissue, we hypothesized that serum proteins derived from several calcium-binding noncollagenous proteins (NCPs) of bone and teeth also may be associated with pathologically mineralized BHVs. Using a rat subdermal model of BHV calcification, glutaraldehyde-preserved bovine pericardium (GPBP) was implanted for 1, 3, 14, and 60 days, and then subjected to an extraction procedure designed to isolate only NCPs tightly bound to the mineral phase. Gel electrophoresis and Coomassie Brilliant Blue staining demonstrated that these proteins became associated with GPBP over time, paralleling reported calcium uptake by the tissue. Stains-All staining demonstrated a marked accumulation of highly acidic, phosphorylated NCPs associated with 60-day GPBP extracts. Some of these proteins were detected in rat serum but were absent from extracts of GPBP incubated in rat serum in vitro. Western blotting with antibodies to three NCPs found in bone and teeth-bone acidic glycoprotein 75 (BAG 75), osteopontin, and SPARC-demonstrated that these NCPs were tightly bound to the mineral phase of calcified GPBP. A fourth NCP, bone sialoprotein II (BSP II) was barely detectable. Thus each identified NCP showed a different pattern of GPBP association relative to mineral deposition, suggesting unique roles for each in pathologic calcification. SPARC increased within 3 days of GPBP implantation but decreased by 2 weeks. BAG 75 and osteopontin uptake was detected in the initial mineral deposits and increased mineralization proceeded. BSP II never increased significantly over the entire-period. Further studies, which should include immunohistochemistry, will be important for delineating the source, location, and function of these three NCPs and for identifying others that also may be involved in this pathological process. Most important, the new insights into the mechanism of pathologic calcification described here present exciting opportunities for novel approaches to BHV calcification prevention.
戊二醛保存的生物人工心脏瓣膜(BHVs)钙化会导致其临床失效。这种病理性钙化的机制尚未明确。由于已知血清蛋白会被矿化组织摄取,我们推测源自骨骼和牙齿的几种钙结合非胶原蛋白(NCPs)的血清蛋白也可能与病理性矿化的BHVs有关。使用大鼠皮下BHV钙化模型,植入戊二醛保存的牛心包(GPBP)1、3、14和60天,然后进行提取程序,旨在仅分离紧密结合到矿化相的NCPs。凝胶电泳和考马斯亮蓝染色表明,这些蛋白质随时间与GPBP相关联,与报道的组织钙摄取情况平行。嗜天青染色表明,与60天GPBP提取物相关的高酸性、磷酸化NCPs有明显积累。其中一些蛋白质在大鼠血清中被检测到,但在体外大鼠血清中孵育的GPBP提取物中不存在。用针对在骨骼和牙齿中发现的三种NCPs(骨酸性糖蛋白75(BAG 75)、骨桥蛋白和SPARC)的抗体进行蛋白质印迹分析表明,这些NCPs紧密结合到钙化GPBP的矿化相。第四种NCP,骨唾液蛋白II(BSP II)几乎检测不到。因此,每种鉴定出的NCP相对于矿物质沉积显示出不同的GPBP关联模式,表明每种在病理性钙化中具有独特作用。SPARC在GPBP植入后3天内增加,但在2周时下降。在初始矿物质沉积中检测到BAG 75和骨桥蛋白的摄取,并且矿化增加仍在进行。在整个期间BSP II从未显著增加。进一步的研究,应包括免疫组织化学,对于描绘这三种NCPs的来源、位置和功能以及识别其他可能也参与此病理过程的物质将很重要。最重要的是,此处描述的病理性钙化机制的新见解为预防BHV钙化的新方法提供了令人兴奋的机会。